May 21, 2013

A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.

May 21, 2013

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

May 20, 2013

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.

May 17, 2013

A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

May 15, 2013

A federal drug track-and-trace bill has made it out of a congressional committee.

May 15, 2013

The Food and Drug Administration has approved a drug for a type of lung cancer.

May 15, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

May 15, 2013

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

May 14, 2013

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

May 14, 2013

The Food and Drug Administration will review an experimental contraceptive patch made by Actavis, the drug maker said Tuesday.

May 14, 2013

A Harris Interactive poll released found that 44% of all adults reported getting their flu shot this past season, the second time flu shot penetration has reached that high in four years, and even more are expected to get a flu shot next season.

May 14, 2013

Americans and their health care plans are spending less on medicines and health services. Is that a good thing?

May 14, 2013

Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.

May 14, 2013

A study conducted by researchers at CVS Caremark and Brigham and Women's Hospital and published in the May issue of the American Heart Journal found that non-white patients had 50% greater odds of statin medication nonadherence compared with white patients, while women had 10% greater odds of statin nonadherence compared with men.

May 13, 2013

Drug maker AstraZeneca is encouraging patients with asthma to control their disease and learn about how it may be affecting their lives as part of National Asthma and Allergy Awareness Month, which takes place in May.

May 13, 2013

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

May 10, 2013

Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.

May 10, 2013

The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

May 10, 2013

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

May 9, 2013

The Drug Enforcement Administration collected more than 371 tons of unused medications last month as part of its sixth annual drug take-back program, the agency said.

May 9, 2013

Sears Holdings has appointed Jeff Balagna as EVP and chief information officer, the Kmart parent company said Thursday.

May 9, 2013

Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

May 9, 2013

The November 2011 expiration of Pfizer's patent on the cholesterol drug Lipitor and Ranbaxy Labs' release of the generic version received significant play in the media, particularly due to the theretofore status of Lipitor (atorvastatin calcium) as the drug with the highest sales in the country, $7.7 billion in the United States, according to healthcare analytics firm IMS Health.

May 8, 2013

Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of its recent shareholder meeting.